The gloomy backdrop of rising virus cases casts a dark shadow over Q1. However, we expect the rollout of vaccines will pave the way to a rebound in economic activity in May/June, and that Nordic currencies will benefit from a broader rally in risky assets this year. Next week, monthly GDP data from Norway are likely to show that the mainland economy contracted in November, and energy effects are likely to have dragged headline inflation higher in Norway and Sweden in December.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services